Abstract: With the increasing complexity of Web application functions, JavaScript libraries are widely used to improve development efficiency and user experience. However, many applications do not ...

Netflix is leading the week with two major releases that will appeal to very different audiences. The biggest highlight is “Akhanda 2”, starring legendary actor Nandamuri Balakrishna (Balayya). The ...

Meta is giving Instagram users a rare glimpse into why certain posts are showing up on their Reels, the platform’s feed of algorithmically curated videos. Starting today, users will now see a list of ...

Kimchi has been enjoyed for centuries in Korea. But the spicy fermented cabbage dish has recently gained popularity in other parts of the world not only because of its delicious taste, but because of ...

Dive into the most addictive Hindi shows of 2025 that everyone’s buzzing about. From gripping thrillers to chaotic comedies and courtroom shockers, this list is your perfect binge map. Fresh stories, ...

Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose from 378 million people with the disease in 1990 to 788 million in 2023 as ...

Ocrelizumab (Ocrevus) delayed overall disability progression and worsening of upper limb function in people with primary progressive multiple sclerosis (PPMS) over 144 weeks, the ORATORIO-HAND (O'HAND ...

(RTTNews) - United Therapeutics Corp. (UTHR), Tuesday announced that its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution for the treatment of idiopathic ...

Director of National Intelligence Tulsi Gabbard told Megyn Kelly during an interview this week that there is an ongoing investigation to prove the role U.S.-funded research at the Wuhan Institute of ...

Results come after positive results from a trial among people with idiopathic pulmomary disease. Nerandomilast (BI 1015550) is an investigational oral drug that selectively inhibits phosphodiesterase ...

The is an opinion piece based on the author’s POV and does not necessarily reflect the views of HackerNoon. Story's Credibility Code License The code in this story is for educational purposes. The ...